Natasha Roy

A new Supreme Court order will continue to allow patients to get mifepristone—one of two drugs commonly used in U.S. medication abortions—via telehealth, through the mail, or from a pharmacy. The Court on May 14, 2026 kept in place its stay of a Fifth Circuit Court of Appeals ruling blocking a Food and Drug Administration (FDA) rule that permitted a widely used abortion pill to be dispensed via telehealth or at a pharmacy.

The Supreme Court temporarily restored access to the abortion drug mifepristone when dispensed at pharmacies and sent by mail on May 4, 2026 as it considers a lower-court decision in Louisiana’s fight against abortion pills. The justices were asked to weigh in after the Fifth Circuit Court of Appeals on May 1 granted Louisiana’s request to block a 2023 Food and Drug Administration (FDA) rule that allows mifepristone to be provided by pharmacies and via telehealth.